There's still a lot to like about Eli Lilly stock, an analyst said Wednesday after the weight-loss drugs kingpin cut its ...
Investor's Business Daily on MSN44m
Eli Lilly: What's Left To Like? A Lot, Says One Analyst.There's still a lot to like about Eli Lilly stock, an analyst said Wednesday after the weight-loss drugs kingpin cut its sales view.
The news media is too focused on small moves in Nvidia stock when they should be considering longer-term trends, a Wall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback